[{"bbox": [88, 96, 371, 132], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [88, 168, 1561, 237], "category": "Text", "text": "solutions. Patient self-testing holds a 10% share, reflecting the increasing preference for home-based diagnostics. Academic institutes and other segments, comprising 4% and 5% respectively, contribute to research and specialized testing."}, {"bbox": [88, 264, 482, 301], "category": "Section-header", "text": "## Market Segmentation by Region"}, {"bbox": [88, 329, 1561, 493], "category": "Text", "text": "The In-Vitro Diagnostics (IVD) market in India is experiencing significant growth, spurred by advancements in diagnostic technology, increased healthcare investments, and a rising demand for personalized and early disease detection solutions. With a focus on precision medicine and self-testing, the IVD market is expanding rapidly across different regions of the country. Each region is witnessing unique trends and growth opportunities, influenced by local healthcare needs, government initiatives, and evolving consumer behaviour. Below is a regional breakdown of the IVD market in India in 2024 and its expected growth until 2030."}, {"bbox": [104, 530, 1325, 1176], "category": "Picture"}, {"bbox": [104, 1202, 595, 1240], "category": "Text", "text": "Source: Imarc Research, CareEdge Research"}, {"bbox": [88, 1274, 1561, 1565], "category": "Text", "text": "**North India:** In 2024, the IVD market in North India is estimated at USD 556 Million. This region, which includes prominent cities like Delhi, Chandigarh, Lucknow, and Jaipur, boasts a strong presence of multispecialty hospitals, diagnostic networks, and research institutions that encourage the uptake of advanced IVD technologies. The increasing demand for molecular diagnostics, immunoassays, and point-of-care testing (POCT) is driven by the high prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. Moreover, government-backed programs like Ayushman Bharat and the National Health Mission (NHM) are improving diagnostic infrastructure, particularly in tier 2 and tier 3 cities, thereby making affordable IVD solutions more accessible. Additionally, the growing popularity of self-testing for conditions like diabetes and infectious diseases is further boosting market growth. The North India IVD market is projected to reach USD 641 Million in 2025, driven by the increased demand for POCT, self-testing solutions, and expanding research collaborations in diagnostics."}, {"bbox": [88, 1594, 1561, 1822], "category": "Text", "text": "**South India:** The IVD market in South India is projected to reach USD 446 Million in 2024. South India is also experiencing a broad adoption of advanced diagnostic methodologies such as next-generation sequencing (NGS), liquid biopsy, and multiplex PCR testing. In addition, key government initiatives like the Tamil Nadu Health Systems Project, Telangana Diagnostics, and Kerala's eHealth Program are enhancing diagnostic facilities, particularly in underserved rural regions. South India is also a prominent centre for the manufacturing of medical devices, with states like Karnataka and Tamil Nadu leading the production. By 2025, the South Indian IVD market is forecast to reach USD 516 Million, driven by the growth of digital diagnostics, the expansion of telemedicine, and the continuous support of government-led healthcare programs."}, {"bbox": [88, 1848, 1561, 2078], "category": "Text", "text": "**West and Central India:** In 2024, the IVD market in West and Central India is valued at USD 361 Million. This region, comprising states like Maharashtra, Gujarat, Madhya Pradesh, and Chhattisgarh, is witnessing substantial growth due to the rapid development of diagnostic facilities in major urban centres such as Mumbai, Pune, Ahmedabad, and Indore. The adoption of cutting-edge technologies like molecular diagnostics, immunoassays, and point-of-care testing (POCT) is gaining momentum, fuelled by the presence of prominent hospitals, diagnostic networks, and research institutions. Moreover, cities like Pune and Ahmedabad are emerging as key innovation hubs, with industrial zones and biotech clusters driving significant research and development in diagnostics, especially in genetic testing and biomarker discovery. By 2025, the market in this region is projected to grow to USD"}]